Literature DB >> 26939560

Retinectomy vs vitrectomy combined with scleral buckling in repair of posterior segment open-globe injuries with retinal incarceration.

Y Wei1,2, R Zhou2, K Xu3, J Wang2, Z Zu2.   

Abstract

PurposeTo evaluate the anatomic and functional outcome of pars plana vitrectomy (PPV) combined with scleral buckling (SB) vs retinectomy in treating posterior segment open-globe injuries with retinal incarceration.MethodsPatients (38 eyes) with posterior segment open-globe injuries and retinal incarceration were identified, and they underwent either PPV combined with SB (PPV+SB, n=19) or retinectomy (n=19). The two groups were matched in the following categories: the severity of injury (including wound length), the location of the incarceration site and the presence of retinal detachment. Anatomic reattachment of the retina and best-corrected visual acuity (BCVA) were measured at the time of 12 months after operation.ResultsAt 12 months after operation, the PPV+SB group demonstrated a better anatomic retinal attachment rate (84.2% vs 68.4%, P=0.252) and BCVA (73.7% vs 47.4%, P=0.247) compared with the retinectomy group, however, the differences failed to reach statistical significance. Compared with the PPV+SB group, the rectinectomy group had significantly higher rates of hemorrhage (47.4% vs 15.8%, P=0.036), inflammation (42.1% vs 10.5%, P=0.027), and a lower intraocular pressure (IOP, 9.8±3.1 vs 13.6±4.1 mmHg, P=0.002) after silicone oil (SO) removal.ConclusionsFor patients with posterior segment open-globe injuries and retinal incarceration, PPV and SB treatments resulted in a better anatomic and functional outcome and less post-operation complications compared with the retinectomy.

Entities:  

Mesh:

Year:  2016        PMID: 26939560      PMCID: PMC4869139          DOI: 10.1038/eye.2016.26

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  12 in total

1.  The prognostic significance of a system for classifying mechanical injuries of the eye (globe) in open-globe injuries.

Authors:  Dante J Pieramici; Kah-Guan Au Eong; Paul Sternberg; Marta J Marsh
Journal:  J Trauma       Date:  2003-04

2.  Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome.

Authors:  J A Cardillo; J T Stout; L LaBree; S P Azen; L Omphroy; J Z Cui; H Kimura; D R Hinton; S J Ryan
Journal:  Ophthalmology       Date:  1997-07       Impact factor: 12.079

3.  Deadly weapon-related open-globe injuries: outcome assessment by the ocular trauma classification system.

Authors:  G Sobaci; F M Mutlu; A Bayer; S Karagül; E Yildirim
Journal:  Am J Ophthalmol       Date:  2000-01       Impact factor: 5.258

4.  Prognostic factors in open globe injuries.

Authors:  David Leonardo Cruvinel Isaac; Vinícius Coral Ghanem; Maurício Abujamra Nascimento; Marcelo Torigoe; Newton Kara-José
Journal:  Ophthalmologica       Date:  2003 Nov-Dec       Impact factor: 3.250

5.  Perforating injuries of the eye.

Authors:  E M Eagling
Journal:  Br J Ophthalmol       Date:  1976-11       Impact factor: 4.638

6.  Vitrectomy for perforating eye injuries from shotgun pellets.

Authors:  D V Alfaro; V T Tran; T Runyan; L P Chong; S J Ryan; P E Liggett
Journal:  Am J Ophthalmol       Date:  1992-07-15       Impact factor: 5.258

7.  Factors influencing final visual results in severely injured eyes.

Authors:  W L Hutton; D G Fuller
Journal:  Am J Ophthalmol       Date:  1984-06       Impact factor: 5.258

8.  Primary scleral buckling in open-globe injury involving the posterior segment.

Authors:  T W Stone; N Siddiqui; J G Arroyo; B W McCuen; E A Postel
Journal:  Ophthalmology       Date:  2000-10       Impact factor: 12.079

9.  Surgical results of vitrectomy in ocular trauma.

Authors:  Y Miyake; F Ando
Journal:  Retina       Date:  1983 Fall-Winter       Impact factor: 4.256

10.  Pars plana vitrectomy for severe penetrating injury with posterior segment involvement.

Authors:  T A Meredith; P A Gordon
Journal:  Am J Ophthalmol       Date:  1987-04-15       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.